Point-of-care Molecular Diagnostics instruments – Tecan to industrialize and supply commercially manufactured Diagnostics instruments – First demonstration instruments delivered – Commercial launch of Enigma ML for initial use is anticipated in Q4 2010 Männedorf, Switzerland and Oxford, UK — The Tecan Group (SIX Swiss Exchange: TECN), a leading global provider of laboratory instruments and solutions, […]
First Commercial Test using SEQureDx Technology for Determining Rhesus D Incompatibility SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM) today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company’s first laboratory developed test powered by its SEQureDx™ […]
MANCHESTER, England & NEW YORK–Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial […]
CHICAGO & SANTA CLARA, Calif.–Linden LLC, a Chicago-based healthcare private equity firm, today announced it has acquired Hycor Biomedical Inc. from Agilent Technologies (NYSE:A). Hycor develops, manufactures and markets in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets. Agilent acquired Hycor through its acquisition of Stratagene in 2007. The terms of the […]
Glasgow, Scotland — D3 Technologies Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS), today announced that it has appointed David Burns as its new Chief Executive Officer. He will lead the Company towards the international launch of its […]
SAVANNAH, Ga.–Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion (Pink Sheets: VRML), formerly known as Ciphergen Biosystems, Inc. In 2006, Health Discovery Corporation sued Ciphergen Biosystems in Federal District Court for infringement of […]
REDMOND, Wash.–Micronics, Inc. today announced that it has been issued a second letters patent from the United States Patent and Trademark Office (USPTO) for an integrated heat exchange system on a disposable, plastic cartridge. The new patent has broad utility across the life sciences sector with particular application in point of care molecular diagnostics. “System […]
VANCOUVER, British Columbia–Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products, expanding its strategic presence in this important global market. “In 2009, we recognized a significant portion of our revenues from sales in China. […]
RENO, Nev.–IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen. Predicant Biosciences, a California-based biotechnology company, developed technology and intellectual property to identify complex protein patterns in blood to detect and diagnose disease, methods to relate genotypes to phenotypes, and techniques to […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM) today announced that Dr. Wolfgang Holzgreve has joined the company’s Clinical Advisory Board. Dr. Holzgreve currently serves as Director and Chairman of the Board of Directors at the University Hospital Freiburg, Germany. “We are very pleased to welcome Wolfgang to our Clinical Advisory Board,” said Dr. Allan Bombard, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
